By Matt Jones

NEW YORK (GenomeWeb News) – Genetic tests sold directly to consumers that provide predictions on disease risk have made some personalized medicine watchers wary that these tests could cause unnecessary psychological stress and worry among customers about their risk of disease, but a new study from Mayo Clinic suggests that those worries may be minimal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.